Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 29.90
+0.65 (2.22%)
At close: Feb 11, 2026
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 23.04 billion as of February 20, 2026. Its market cap has decreased by -28.86% in one year.
Market Cap
23.04B
Enterprise Value
25.39B
Revenue
70.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.90
Market Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 23.04B, a decrease of -50.41%. That is a compound annual growth rate of -6.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 23.04B | -3.86% |
| Dec 31, 2025 | 23.96B | -29.66% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 43.78B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 30.15B |
| Oneness Biotech | 27.84B |
| Sunmax Biotechnology | 21.21B |
| EirGenix | 18.52B |
| TaiMed Biologics | 14.67B |
| AP Biosciences | 14.38B |